utraceutical evaluation and assessment of Balya Karma of Shalmali pushpa (Bombax ceiba LINN.)- A single blind randomized placebo controlled clinical trial

All India Institute of Ayurveda0 个研究点目标入组 66 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1.Subjects within age group 21-40 years irrespective of gender, caste and religion
•2.Patients having lower body mass index (BMI) (less than 18.5) with clinical features of Karshya.
•3.Those subjects who will be ready to sign informed consent form.
•4.Subjects who are not taking any type of protein supplementation for more than 6 months

•1.Subjects not willing for trial & follow up
•2.Patients having BMI < 16 (severe thinness)
•3.Hyper or Hypothyroidism
•4.Subjects on Multi-vitamin or protein supplementation
•5.Pregnant women or lactating mothers
•6.Patients having any systemic disease or history of chronic diseases such as diabetes mellitus, tuberculosis, cancer and autoimmune diseases which cause weight loss
•7.Subjects with acute and chronic infections, Mal-absorption syndrome and Inborn errors of metabolism
•8.Patients who have completed participation in any other clinical trial during the past 2 months

发起方